Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06367465 · ClinicalTrials.gov registry record
Feasibility and Acceptability of HCV Treatment in Pregnancy
A clinical trial of Hepatitis C and Pregnancy Complications, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- 50
- Enrollment target
- 2
- Study locations
NCT06367465 is a study of Hepatitis C and Pregnancy Complications that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 50 participants, below the 1,890-participant average among 106 other Hepatitis C trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT06367465, a study of Hepatitis C and Pregnancy Complications, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 2
- Study locations
Study Summary
Pregnant adults over the age of 18 who are seen in the Washington University obstetrics and gynecology, maternal fetal medicine or infectious diseases clinic or admitted to BJH with hepatitis C virus infection who have a history of past or current drug use Participant Duration: Approximately 1 year. Aims: Aim 1 - Evaluate adherence and treatment completion rates when glecaprevir-pibrentasvir is started during pregnancy for women who use drugs. Aim 2 - Evaluate patient experience with hepatitis C virus treatment during pregnancy.
Conditions Studied
Interventions
- DRUG Glecaprevir-pibrentasvir
Study Locations (2)
Missouri
- Barnes Jewish Hospital - St Louis
- Washington Univeristy - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-02-01 |
| Est. Completion | 2026-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06367465
The ClinicalTrials.gov registry entry for NCT06367465 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,890-participant average among 106 other Hepatitis C trials with a reported enrollment target (97% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hepatitis C appearing as the primary indexed condition, and to 1 intervention - of which Glecaprevir-pibrentasvir is the first listed.
NCT06367465 reports 2 study locations spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT06367465 about?
NCT06367465 is a clinical study titled "Feasibility and Acceptability of HCV Treatment in Pregnancy". Pregnant adults over the age of 18 who are seen in the Washington University obstetrics and gynecology, maternal fetal medicine or infectious diseases clinic or admitted to BJH with hepatitis C virus infection who have a history of past or current drug use Participant Duration: Approximately 1 year...
What is the current status of trial NCT06367465?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2024-02-01. Estimated completion is 2026-02-28.
What conditions does trial NCT06367465 study?
This clinical trial studies the following conditions: Hepatitis C, Pregnancy Complications.
What interventions are being tested in trial NCT06367465?
The interventions under investigation include: Glecaprevir-pibrentasvir (DRUG).
Who is sponsoring clinical trial NCT06367465?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06367465 being conducted?
This trial has 2 study locations across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatitis C
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
DBS TaT in Peer-assisted Telemedicine for Hepatitis C
RECRUITING · NA
-
Evaluation of Patients With Liver Disease
RECRUITING
-
The HOPE Study: Characterizing Patients With Hepatitis B and C
RECRUITING
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs
RECRUITING · NA
-
The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.